Compare Stocks → Move Your Money Before May 22 (From Stansberry Research) (Ad) Compare stocks and their fundamentals, performance, price, and technicals. Use this free stock comparison tool to evaluate companies based on their analyst ratings, book value, debt, dividend, MarketRank, news sentiment, price performance, profitability, and more. Enter up to ten stock symbols separated by a comma or space (ex. BAC, JPM, WFC, C, GS). Comparison Ideas Agriculture StocksAirline StocksApparel StocksArtificial Intelligence StocksAutomotive StocksBank StocksBitcoin StocksBlockchain StocksCanadian StocksCannabis StocksCasino StocksChatGPT StocksChinese StocksCloud Storage StocksCoronavirus Therapeutics StocksCryptocurrency StocksCybersecurity StocksDefense StocksDividend StocksDow 30 StocksEcommerce StocksElectric Vehicles StocksEnergy StocksEntertainment StockseSports StocksEV Charging StocksFertilizer StocksGold StocksGrocery StocksGrowth StocksHealthcare StocksHigh Dividend StocksHome Office StocksHotel StocksLarge Cap StocksLeisure StocksLithium StocksMagnificent Seven StocksMATANA StocksMega Cap StocksMeme StocksMetaverse StocksMid Cap StocksMining StocksMusic Industry StocksNanotechnology StocksNFT StocksOil StocksOutdoor Activities StocksPharmaceutical StocksRenewable Energy StocksRestaurant StocksRetail StocksSemiconductor StocksSocial Media StocksSolar StocksSpace StocksStay-At-Home StocksTechnology StocksTelecom StocksToy StocksUtility StocksVaccine StocksVideo Game StocksVirtual Reality StocksWallStreetBets Stocks Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare Share Comparison Share Comparison NYSE:ARANYSE:TAM Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Stocks - Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeARAAmerican Renal Associates$11.52$11.50$5.57▼$11.98$397.94M1.11106,940 shs9,831 shsTAM(TAM)$0.00$18.95▼$26.96N/AN/A330,661 shsN/AThe 10 Best AI Stocks to Own in 2024Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.Get This Free ReportPrice PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceARAAmerican Renal Associates0.00%0.00%0.00%0.00%0.00%The Gold Grab of the Century (Ad)When central banks buy gold… The rich buy right along with them. And central banks are buying at breakneck pace. Last year… 1,037 tons. Just 45 tons less than the record set two years ago.That's why we have released our Free Precious Metals Investment Guide.MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationARAAmerican Renal AssociatesN/AN/AN/AN/AN/AN/AN/AN/ATAM(TAM)N/AN/AN/AN/AN/AN/AN/AN/AAnalyst RatingsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceARAAmerican Renal AssociatesN/AN/AN/AN/ATAM(TAM)N/AN/AN/AN/ASales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookARAAmerican Renal Associates$822.52M0.48$1.69 per share6.80$2.59 per share4.45TAM(TAM)N/AN/AN/AN/AN/AN/AProfitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateARAAmerican Renal Associates-$13.79M$0.26N/AN/AN/A-2.04%-3.56%-0.24%N/ATAM(TAM)N/AN/A0.00N/AN/AN/AN/AN/AN/ADividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthARAAmerican Renal AssociatesN/AN/AN/AN/AN/ATAM(TAM)N/AN/AN/AN/AN/ADebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioARAAmerican Renal Associates7.541.051.02TAM(TAM)N/AN/AN/AOwnershipInstitutional OwnershipCompanyInstitutional OwnershipARAAmerican Renal Associates78.42%TAM(TAM)N/AInsider OwnershipCompanyInsider OwnershipARAAmerican Renal Associates9.50%TAM(TAM)N/AMiscellaneousCompanyEmployeesShares OutstandingFree FloatOptionableARAAmerican Renal Associates4,97734.54 millionN/AOptionableTAM(TAM)N/AN/AN/ANot OptionableBRNA, ARA, VTH, and TAM HeadlinesSourceHeadlineTam McManus names 13 Hibs flops who should be axed in dead wood summer clearout but Nick Montgomery NEEDS to staymsn.com - April 26 at 12:00 PMVeteran Hong Kong teacher fired and who lost pension over 2019 unrest Facebook posts wins appeal against ‘harsh and oppressive’ decisionmsn.com - April 26 at 12:00 PMI know every player that MUST leave Hibs this summer and it shows Nick Montgomery needs more time – Tam McManusmsn.com - April 26 at 1:11 AMNescafé and Arnott’s Tim Tam team up on new product launchfoodmag.com.au - April 26 at 1:11 AMThe best (and worst) moments that made the Kentucky Derby the holy grail of horse racingmsn.com - April 25 at 8:11 PMGezellig Brewing Company brews new batch of tulip-flavored beer for Tulip Timemsn.com - April 25 at 12:08 AMMalaysia govt mulls second Genting casino, says reportggrasia.com - April 25 at 12:08 AMGirls lacrosse: Marin Catholic returns to MCAL finale for another shot at pennantmarinij.com - April 25 at 12:08 AMArtificial Intelligence Makes Retinal Imaging 100 Times Fasteremjreviews.com - April 24 at 9:04 AMLeanne Tamscmp.com - April 24 at 1:51 AMSports Briefs: MCAL baseball playoff race tightens after thrilling day on diamondmarinij.com - April 24 at 1:51 AMTam Dao builds cultural villages associated with tourism developmentvietnamnet.vn - April 23 at 8:49 PMBoys lacrosse: Vasquez looking to go out with title at Redwoodmarinij.com - April 23 at 8:49 PMNew owners update Super 8 near Tam O'Shanter as 1 Kelso hotel says tourism uptdn.com - April 23 at 8:35 AMMarin Voice: Crossing guards benefit our entire communitymarinij.com - April 23 at 3:34 AMPreps of the week: Redwood tennis claims first title of the springmarinij.com - April 22 at 10:34 PMOwls Clinch Playoff Spot With Split at Bushnellkdrv.com - April 22 at 10:34 PMTam Union school district proposes e-bike registration programmarinij.com - April 22 at 10:34 PMNew Astrica CEO On Building A Women-Led Business, Going All In On ServiceNowcrn.com - April 22 at 5:33 PMBemz, Bobby Madden and Ryan Stevenson join Stuart and Tambbc.co.uk - April 22 at 5:33 PMActivities towards national sea and islandsen.qdnd.vn - April 22 at 12:33 PMIPL 17 advertising sees significant growth with 59% increase in categories and 38% rise in advertisers compared to IPL 16, reveals TAM reportfinancialexpress.com - April 22 at 7:33 AMBill establishing labor standards in Hawaii moves forwardnews.yahoo.com - April 21 at 3:46 PMFootball fans stunned after spotting Jonathan Van-Tam at match dressed as a nunmsn.com - April 21 at 3:46 PMTop Headlines3 Value Stocks Too Small For Buffett’s PortfolioMarch 28, 2024 12:16 PMView 3 Value Stocks Too Small For Buffett’s PortfolioStock market today: Alphabet and Microsoft push Wall Street toward its first winning week in a monthApril 26, 2024 3:21 AMView Stock market today: Alphabet and Microsoft push Wall Street toward its first winning week in a monthCaterpillar’s Market Reset Isn’t Over: Get Ready for Lower PricesApril 25, 2024 10:36 AMView Caterpillar’s Market Reset Isn’t Over: Get Ready for Lower PricesFoot Locker Builds Up Another Head of Steam; Gains ImminentMarch 28, 2024 10:58 AMView Foot Locker Builds Up Another Head of Steam; Gains ImminentWhat is a Secular Bull Market? How to Identify this MarketApril 16, 2024 7:59 AMView What is a Secular Bull Market? How to Identify this MarketAll Headlines Company DescriptionsAmerican Renal AssociatesNYSE:ARAAmerican Renal Associates Holdings, Inc. operates as a dialysis services provider in the United States. It operates dialysis clinics focusing on joint venture partnerships with physicians. The company offers kidney dialysis services to patients suffering from chronic kidney failure or end stage renal disease. As of December 31, 2019, it operated 246 dialysis clinics in partnership with 400 nephrologist partners treating approximately 17,300 patients in 27 states and the District of Columbia. The company was founded in 1999 and is headquartered in Beverly, Massachusetts.(TAM)NYSE:TAMTaminco Corp is a producer of alkylamines and alkylamine derivatives. The Company's products are used by its customers in the manufacturing of everyday products primarily for the agriculture, water treatment, personal and home care, animal nutrition and oil and gas end-markets. It operates in 19 countries with seven production facilities and, as of December 31, 2012, had an installed production capacity of 1,272 thousand tons. The Company has three business segments: Functional Amines, Specialty Amines, and Crop Protection. In March 2014, the Company announced that it completed the acquisition of the formic acid business of Kemira Oyj. Its main shareholder is Eastman Chemical Company. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
